169.52 USD
-0.48
0.28%
At close Dec 20, 4:00 PM EST
After hours
169.52
+0.00
0.00%
1 day
-0.28%
5 days
-3.68%
1 month
2.77%
3 months
39.61%
6 months
30.01%
Year to date
47.91%
1 year
49.04%
5 years
6.90%
10 years
540.42%
 

About: Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Employees: 3,796

0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

89% more call options, than puts

Call options by funds: $80.4M | Put options by funds: $42.6M

11% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 54

6% more capital invested

Capital invested by funds: $6.29B [Q2] → $6.68B (+$384M) [Q3]

2% more funds holding

Funds holding: 347 [Q2] → 353 (+6) [Q3]

0.29% more ownership

Funds ownership: 93.97% [Q2] → 94.26% (+0.29%) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 3 (+0) [Q3]

12% less repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 121

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$170
0%
upside
Avg. target
$187
10%
upside
High target
$210
24%
upside

5 analyst ratings

positive
100%
neutral
0%
negative
0%
Piper Sandler
Jason Bednar
50% 1-year accuracy
19 / 38 met price target
24%upside
$210
Overweight
Maintained
18 Dec 2024
Wells Fargo
Vik Chopra
80% 1-year accuracy
8 / 10 met price target
14%upside
$193
Overweight
Maintained
11 Dec 2024
Stifel
Rick Wise
62% 1-year accuracy
18 / 29 met price target
12%upside
$190
Buy
Reiterated
22 Nov 2024
Raymond James
Jayson Bedford
66% 1-year accuracy
19 / 29 met price target
0%upside
$170
Outperform
Upgraded
6 Nov 2024
BTIG
Marie Thibault
85% 1-year accuracy
11 / 13 met price target
0%upside
$170
Buy
Maintained
14 Oct 2024

Financial journalist opinion

Based on 4 articles about MASI published over the past 30 days

Positive
Zacks Investment Research
2 days ago
4 Healthcare Technology Innovators to Invest in Before the New Year
Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT.
4 Healthcare Technology Innovators to Invest in Before the New Year
Positive
Zacks Investment Research
5 days ago
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
MASI, PEN and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar their prospects.
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
Neutral
Zacks Investment Research
3 weeks ago
Buy 5 Mid-Cap Stocks Poised to Turn Into Large Caps in 2025
These mid-cap stocks have the potential to become large-caps in 2025. These are: MTSI, MASI, DRS, CRS, INGR.
Buy 5 Mid-Cap Stocks Poised to Turn Into Large Caps in 2025
Neutral
Business Wire
3 weeks ago
Masimo to Present in the Piper Sandler 36th Annual Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 8:30 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide arr.
Masimo to Present in the Piper Sandler 36th Annual Healthcare Conference
Neutral
Business Wire
1 month ago
Masimo to Present in the Jefferies London Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-l.
Masimo to Present in the Jefferies London Healthcare Conference
Neutral
Business Wire
1 month ago
Masimo to Present in Stifel 2024 Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industr.
Masimo to Present in Stifel 2024 Healthcare Conference
Positive
Zacks Investment Research
1 month ago
MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands
Masimo's third-quarter 2024 results continue to benefit from the strength in its Healthcare business.
MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands
Neutral
Seeking Alpha
1 month ago
Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript
Masimo Corporation (NASDAQ:MASI ) Q3 2024 Earnings Conference Call November 5, 2024 4:30 PM ET Company Participants Eli Kammerman - VP of Business Development and IR Michelle Brennan - Interim CEO Micah Young - EVP and CFO Bilal Muhsin - COO Conference Call Participants Jason Bednar - Piper Sandler Marie Thibault - BTIG Michael Polark - Wolfe Research Frederick Wise - Stifel Matt Taylor - Jefferies Vik Chopra - Wells Fargo Michael Matson - Needham Jayson Bedford - Raymond James Operator Ladies and gentlemen, good afternoon, and welcome to Masimo's Third Quarter 2024 Earnings Conference Call. The company's press release is available at www.masimo.com.
Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Masimo (MASI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Masimo (MASI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Positive
Zacks Investment Research
1 month ago
Masimo (MASI) Q3 Earnings and Revenues Top Estimates
Masimo (MASI) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.63 per share a year ago.
Masimo (MASI) Q3 Earnings and Revenues Top Estimates
Charts implemented using Lightweight Charts™